Previous 10 | Next 10 |
2024-03-06 11:25:10 ET Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors, computer processing hardware and the computer peripherals industries. Additionally, the biotech sector is +13.6% in 2024, outdoing all of the major market aver...
BALA CYNWYD, Pa., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of its previously announced underwritten public o...
2024-02-16 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-15 09:45:10 ET Coinbase Global Inc (COIN) COIN is trading UP for the last 5 days, and it at trading at $168.00 with volume of 8,158,758 and a one day change of $7.62 (4.75%). Coinbase Global Inc has a 52-week low of 32.58 and a 52-week high of $121.46. The business's 50-day ...
2024-02-14 13:54:31 ET More on Mid-day movers & stocks. Financial information for Brera Holdings PLC Financial information for Datasea Seeking Alpha’s Quant Rating on Tenon Medical Historical earnings data for Tenon Medical Financial inform...
2024-02-14 06:37:40 ET Read the full article on Seeking Alpha For further details see: Larimar Therapeutics rises after pricing $150M stock offering
BALA CYNWYD, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public o...
2024-02-13 17:30:16 ET Gainers: Lyft ( LYFT ) +18% . Larimar Therapeutics ( LRMR ) +15% . CEVA ( CEVA ) +9% . Robinhood Markets ( HOOD ) +9% . FibroBiologics ( FBLG ) +8% . Losers: QuidelOrtho Corporation ( QDEL ) -...
2024-02-13 16:22:15 ET More on Larimar Therapeutics Larimar aiming to file for accelerated approval in 2H 2025 Seeking Alpha’s Quant Rating on Larimar Therapeutics Historical earnings data for Larimar Therapeutics Financial information for Larimar Ther...
BALA CYNWYD, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an underwritten public offering of shar...
News, Short Squeeze, Breakout and More Instantly...
Larimar Therapeutics Inc. Company Name:
LRMR Stock Symbol:
NASDAQ Market:
First patient dosed in open label extension (OLE) study with 25 mg daily dosing of nomlabofusp; interim data on track for Q4 2024 Positive top-line Phase 2 dose exploration study data demonstrated nomlabofusp was generally well-tolerated with dose-dependent increases in tissue frataxin le...
2024-04-26 19:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-16 22:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...